| Literature DB >> 31867221 |
Zhengzheng Liao1, Jing Nie1, Peiwen Sun1.
Abstract
Accumulating evidence suggests that particulate matter (PM2.5), as a major air pollutant, imposes a certain degree of destruction and toxicity to the skin. It particularly impairs the structure and function of the epidermis. To study the impact of PM2.5 on the skin, transcriptome analysis was performed on PM2.5-exposed human primary keratinocytes. Functional annotation analysis demonstrates that PM2.5 significantly up-regulates cholesterol-metabolism-related genes. Via lipid extraction from PM2.5 treated three-dimensional epidermis tissue model (3D-ETM) and subsequent characterization via mass spectrometry, it was confirmed that PM2.5 significantly increases epidermal cholesterol levels in vitro. Conversely, the amount of squalene in 3D-ETM was significantly reduced by PM2.5. Interestingly, neither cholesterol nor squalene showed significant fluctuations in the green tea extract (GTE) treated epidermis tissue model under PM2.5 exposure. This study shows that PM2.5 may cause barrier disorders by increasing cholesterol synthesis, leading to transient accumulation of epidermal cholesterol and decrease of squalene. It was suggested that cholesterol and squalene, which are the key substances affecting skin barrier function, can be used as new biomarkers of skin damage induced by PM2.5. Moreover, it was demonstrated that GTE can reduce damage caused by PM2.5 exposure by not only anti-inflammatory and antioxidant mechanisms, but also by off-setting the disturbance to epidermal lipid homeostasis. This study demonstrates the strong potential of GTE as an active ingredient to be utilized in cosmetic products to effectively reduce the damage PM2.5 induces in skin.Entities:
Keywords: 3D-epidermis tissue model; Cholesterol metabolism; Green tea extract; PM2.5; Squalene; Transcriptome analysis
Year: 2019 PMID: 31867221 PMCID: PMC6906712 DOI: 10.1016/j.toxrep.2019.11.014
Source DB: PubMed Journal: Toxicol Rep ISSN: 2214-7500
Chemical analysis of PM2.5 sample collected in Xi'an China.
| Elemental species(μg/m3) | |||||||||||
| S | Ti | Cr | Mn | Fe | Ni | Zn | As | Br | Mo | Cd | Pb |
| 3.4 | 0.12 | 0.01 | 0.13 | 1.42 | 0 | 2.28 | 0.02 | 0.06 | 0.05 | 0.02 | 0.29 |
| Ionic species(μg/m3) | |||||||||||
| K+ | Na+ | NH4+ | NO3− | SO42− | Mg2+ | Ca2+ | Cl− | F− | |||
| 1.14 | 1.5 | 4.32 | 9.32 | 13.3 | 0.18 | 2.24 | 3.83 | 0.15 | |||
| Carbonaceous components(μg/m3) | |||||||||||
| Total carbon | Organic carbon | Elemental carbon | water-soluble organic carbon | ||||||||
| 26.7 | 22.43 | 4.27 | 7.62 | ||||||||
Fig. 1The viability (A) and morphology (B) of keratinocytes treated with different concentrations of PM2.5.
Fig. 2Gene expression profiles of PM2.5-treated group (KC_PM2.5) vs. control group (KC_SC). (A) The heat map showing the gene expression levels of keratinocytes under the treatment of PM2.5 versus the control group. The color indicate the relative expression level of the gene. Only genes with padj< 0.001 were shown in the heat map. padj refers to the multiple testing corrected p values. (B) The volcano plot. The horizontal axis represents fold change; while the vertical axis represents statistically significant difference. Red dots: significantly up-regulated genes, green dots: significantly down-regulated genes.
Top 30 significantly up-regulated genes in the keratinocytes treated with PM2.5.
| Associated Gene Name | log2.Fold change. | pvalue | padjue | Description |
|---|---|---|---|---|
| CXCL1 | 3.3047 | 1.37E-06 | 0.00045496 | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
| CYP1A1 | 2.7319 | 4.01E-11 | 2.83E-08 | cytochrome P450 family 1 subfamily A member 1 |
| S100A8 | 2.6565 | 5.16E-07 | 0.0001883 | S100 calcium binding protein A8 |
| EIF3CL | 2.4628 | 7.74E-09 | 3.76E-06 | eukaryotic translation initiation factor 3 subunit C-like |
| S100A9 | 2.319 | 1.79E-09 | 9.31E-07 | S100 calcium binding protein A9 |
| HMGCS1 | 1.8909 | 4.51E-42 | 1.64E-38 | 3-hydroxy-3-methylglutaryl-CoA synthase 1 |
| IL1RN | 1.689 | 6.44E-10 | 3.71E-07 | interleukin 1 receptor antagonist |
| INSIG1 | 1.5304 | 9.01E-11 | 5.98E-08 | insulin induced gene 1 |
| KRT6B | 1.3754 | 4.66E-12 | 3.51E-09 | keratin 6B, type II |
| TNFAIP3 | 1.3361 | 8.01E-19 | 1.17E-15 | TNF alpha induced protein 3 |
| SERPINB2 | 1.3277 | 2.99E-16 | 3.63E-13 | serpin peptidase inhibitor, clade B (ovalbumin), member 2 |
| SOD2 | 1.3093 | 3.74E-10 | 2.27E-07 | superoxide dismutase 2, mitochondrial |
| NFKBIA | 1.2489 | 9.67E-08 | 3.92E-05 | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
| TXNRD1 | 1.2116 | 2.89E-15 | 3.28E-12 | thioredoxin reductase 1 |
| TACSTD2 | 1.1573 | 3.00E-15 | 3.28E-12 | tumor-associated calcium signal transducer 2 |
| HBEGF | 1.1016 | 1.27E-09 | 6.94E-07 | heparin-binding EGF-like growth factor |
| MSMO1 | 1.0632 | 3.23E-20 | 5.04E-17 | methylsterol monooxygenase 1 |
| FASN | 1.0064 | 1.30E-89 | 2.83E-85 | fatty acid synthase |
| ACLY | 0.99489 | 6.19E-24 | 1.04E-20 | ATP citrate lyase |
| ALDH1A3 | 0.98715 | 2.55E-12 | 2.15E-09 | aldehyde dehydrogenase 1 family member A3 |
| SQLE | 0.9585 | 6.93E-11 | 4.74E-08 | squalene epoxidase |
| ACSS2 | 0.95247 | 2.72E-10 | 1.75E-07 | acyl-CoA synthetase short-chain family member 2 |
| FGFBP1 | 0.95138 | 7.90E-40 | 2.47E-36 | fibroblast growth factor binding protein 1 |
| FTL | 0.93974 | 8.68E-19 | 1.19E-15 | ferritin, light polypeptide |
| BHLHE40 | 0.89669 | 9.37E-07 | 0.00031543 | basic helix-loop-helix family member e40 |
| KRT19 | 0.87714 | 1.83E-08 | 8.70E-06 | keratin 19, type I |
| HMGCR | 0.8467 | 2.49E-08 | 1.13E-05 | 3-hydroxy-3-methylglutaryl-CoA reductase |
| IL1B | 0.83678 | 2.44E-06 | 0.00073037 | interleukin 1 beta |
| TFPI2 | 0.8355 | 3.93E-10 | 2.33E-07 | tissue factor pathway inhibitor 2 |
| INHBA | 0.82203 | 3.44E-06 | 0.00099125 | inhibin beta A |
Fig. 3Top 20 GO-terms and pathways of up-regulated genes stimulated by PM2.5.
Cholesterol metabolism related genes.
| Gene Symbol | log2.Fold_change. | pvalue | padjue | Description | Role in cholesterol metabolism |
|---|---|---|---|---|---|
| ACLY | 0.99489 | 6.19E-24 | 1.04E-20 | ATP citrate lyase | Acetyl-Co synthesis |
| ACSS2 | 0.95247 | 2.72E-10 | 1.75E-07 | acyl-CoA synthetase short-chain family member 2 | |
| HMGCR | 0.8467 | 2.49E-08 | 1.13E-05 | 3-hydroxy-3-methylglutaryl-CoA reductase | Cholesterol synthesis step1 |
| HMGCS1 | 1.8909 | 4.51E-42 | 1.64E-38 | 3-hydroxy-3-methylglutaryl-CoA synthase 1 | |
| MVD | 0.75521 | 6.24E-07 | 2.22E-04 | mevalonate diphosphate decarboxylase | Cholesterol synthesis step2 |
| MSMO1 | 1.0632 | 3.23E-20 | 5.04E-17 | methylsterol monooxygenase 1 | |
| FDFT1 | 0.59669 | 4.65E-12 | 3.51E-09 | farnesyl-diphosphate farnesyltransferase 1 | |
| SQLE | 0.9585 | 6.93E-11 | 4.74E-08 | squalene epoxidase | Cholesterol synthesis step3 |
| LSS | 0.68795 | 3.73E-08 | 1.66E-05 | lanosterol synthase | |
| LDLR | 0.69696 | 2.72E-12 | 2.20E-09 | low density lipoprotein receptor | Cholesterol transfer |
| SCD | 0.59881 | 7.25E-61 | 5.29E-57 | stearoyl-CoA desaturase | Fatty acid synthesis |
| FASN | 1.0064 | 1.30E-89 | 2.83E-85 | fatty acid synthase | |
| INSIG1 | 1.5304 | 9.01E-11 | 5.98E-08 | insulin induced gene 1 |
Fig. 4Significantly up-regulated genes involved in cholesterol metabolism.
Fig. 5Gene expression profiles of control (KC_SC), GTE + PM2.5 co-treated (KC_GTE), and PM2.5 treated (KC_PM2.5) samples (A) The heat map showing the gene expression levels of keratinocytes of control, under the treatment of GTE and PM2.5, as well as under the treatment of PM2.5 only. Only genes with padj< 0.001 were shown in the heat map. (B) The volcano plot.
Fig. 6Top 20 GO-terms and pathways of significantly down-regulated genes in PM2.5 and GTE co-treated group.
Fig. 7(A) Fold change in Cholesterol and Squalene level characterized by LC–MS in 3D-ETM. PM2.5/Control: PM2.5-treated 3D-ETM/control 3D-ETM (B) Cholesterol level quantified in epidermis tissue models by LC–MS.